The Company is offering a dedicated support platform called Cycle Vita to provide individualized product support to patients. Ormalvi ™ (dichlorphenamide) has been made available by Cycle ...

Findings showed treatment with delpacibart etedesiran reversed disease progression in DM1 patients based on multiple functional measures. The Food and Drug Administration (FDA) has granted ...

Selarsdi (ustekinumab-aekn) Interleukin-12 and -23 antagonist Treatment of moderate to severe plaque psoriasis and for active psoriatic arthritis in adults and pediatric patients 6 years and older.

At the time of analysis, no cases of post injection delirium syndrome were reported. A once-monthly subcutaneous formulation of olanzapine (TEV-’749) was found to improve symptoms in patients with ...

The table below is a review of notable updates that occurred in April 2024 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

The sensitivity of ColoSense was 94% for detecting colorectal cancer. The Food and Drug Administration (FDA) has approved ColoSense ™, a noninvasive colorectal cancer screening test for adults 45 ...

Credit: Getty Images. What is unusual about this particular case is that it came about due to reliance on an electronic health record system. The EHR that Dr C was using had inexplicably highlighted a ...

The inhalation formulation is expected to deliver treatment directly to the lungs, reducing the potential for systemic toxicity. The Food and Drug Administration (FDA) has granted Fast Track ...

Credit: Masimo. The sensor is contained within the Stork boot, which is secured to the baby’s foot. The system notifies caregivers with visual and audible alarms when oxygen saturation level or PR ...

A Prescription Drug User Fee Act target date of February 28, 2025 has been assigned to the application. Opdivo, a programmed death-1 (PD-1) immune checkpoint inhibitor, is currently available as a ...

Treatment with LYR-210 did not result in a statistically significant improvement in the composite score of 3 cardinal symptoms of CRS compared with sham. Findings from a phase 3 trial evaluating ...

NeuLumEX and Liquid Polibar Plus are expected to be out of stock in May 2024 and August 2024, respectively. Bracco Diagnostics will no longer be producing NeuLumEX ™ (barium sulfate) Suspension, (0.1% ...